The effect of coefficient quantization optimization on filtering performance and gate count

Abstract. Digital filters are an essential component of Digital Signal Processing (DSP) applications and play a crucial role in removing unwanted signal components from a desired signal. However, digital filters are known to be resource-intensive and consume a large amount of power, making it important to optimize their design in order to minimize hardware requirements such as multipliers, adders, and registers. This trade-off between filter performance and hardware consumption can be influenced by the quantization of filter coefficients. Therefore, this thesis investigates the quantization of Finite Impulse Response (FIR) filter coefficients and analyzes its impact on filter performance and hardware resource consumption. A method called dynamic quantization is introduced and an algorithm for step-by-step dynamic quantization is provided to improve upon the results obtained with the classical fixed point quantization method. To demonstrate the effectiveness of this approach, the dynamic quantization of filter coefficients for a Low-pass Equiripple FIR filter is examined and a comparative study of the magnitude response and hardware consumption of the generated filter using both the classical and dynamic quantization methods is presented. By understanding the trade-offs and benefits of each quantization method, engineers can make informed decisions about the most appropriate approach for their specific application

Performance Evaluation of Software using Formal Methods

Formal Methods (FMs) can be used in varied areas of applications and to solve critical and fundamental problems of Performance Evaluation (PE). Modelling and analysis techniques can be used for both system and software performance evaluation. The functional features and performance properties of modern software used for performance evaluation has become so intertwined. Traditional models and methods for performance evaluation has been studied widely which culminated into the modern models and methods for system and software engineering evaluation such as formal methods. Techniques have transcended from functionality to performance modeling and analysis. Formal models help in identifying faulty reasoning far earlier than in traditional design; and formal specification has proved useful even on already existing software and systems. Formal approach eliminates ambiguity. The basic and final goal of the performance evaluation technique is to come to a conclusion, whether the software and system are working in a good condition or satisfactorily

Influence of well-being and quality of work-life on quality of care among healthcare professionals in southwest, Nigeria

The Nigerian healthcare industry is bedevilled with infrastructural dilapidations and a dysfunctional healthcare system. This study investigated the influence of healthcare professionals' well-being and quality of work-life (QoWL) on the quality of care (QoC) of patients in Nigeria. A multicentre cross-sectional study was conducted at four tertiary healthcare institutions in southwest, Nigeria. Participants' demographic information, well-being, quality of life (QoL), QoWL, and QoC were obtained using four standardised questionnaires. Data were summarised using descriptive statistics. Inferential statistics included Chi-square, Pearson's correlation, independent samples t-test, confirmatory factor analyses and structural equation model. Medical practitioners (n = 609) and nurses (n = 570) constituted 74.6% of all the healthcare professionals with physiotherapists, pharmacists, and medical laboratory scientists constituting 25.4%. The mean (SD) participants' well-being = 71.65% (14.65), QoL = 61.8% (21.31), QoWL = 65.73% (10.52) and QoC = 70.14% (12.77). Participants' QoL had a significant negative correlation with QoC while well-being and quality of work-life had a significant positive correlation with QoC. We concluded that healthcare professionals' well-being and QoWL are important factors that influence the QoC rendered to patients. Healthcare policymakers in Nigeria should ensure improved work-related factors and the well-being of healthcare professionals to ensure good QoC for patients

Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

Background Musculoskeletal disorders include more than 150 different conditions affecting joints, muscles, bones, ligaments, tendons, and the spine. To capture all health loss from death and disability due to musculoskeletal disorders, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) includes a residual musculoskeletal category for conditions other than osteoarthritis, rheumatoid arthritis, gout, low back pain, and neck pain. This category is called other musculoskeletal disorders and includes, for example, systemic lupus erythematosus and spondylopathies. We provide updated estimates of the prevalence, mortality, and disability attributable to other musculoskeletal disorders and forecasted prevalence to 2050. Methods Prevalence of other musculoskeletal disorders was estimated in 204 countries and territories from 1990 to 2020 using data from 68 sources across 23 countries from which subtraction of cases of rheumatoid arthritis, osteoarthritis, low back pain, neck pain, and gout from the total number of cases of musculoskeletal disorders was possible. Data were analysed with Bayesian meta-regression models to estimate prevalence by year, age, sex, and location. Years lived with disability (YLDs) were estimated from prevalence and disability weights. Mortality attributed to other musculoskeletal disorders was estimated using vital registration data. Prevalence was forecast to 2050 by regressing prevalence estimates from 1990 to 2020 with Socio-demographic Index as a predictor, then multiplying by population forecasts. Findings Globally, 494 million (95% uncertainty interval 431–564) people had other musculoskeletal disorders in 2020, an increase of 123·4% (116·9–129·3) in total cases from 221 million (192–253) in 1990. Cases of other musculoskeletal disorders are projected to increase by 115% (107–124) from 2020 to 2050, to an estimated 1060 million (95% UI 964–1170) prevalent cases in 2050; most regions were projected to have at least a 50% increase in cases between 2020 and 2050. The global age-standardised prevalence of other musculoskeletal disorders was 47·4% (44·9–49·4) higher in females than in males and increased with age to a peak at 65–69 years in male and female sexes. In 2020, other musculoskeletal disorders was the sixth ranked cause of YLDs globally (42·7 million [29·4–60·0]) and was associated with 83 100 deaths (73 600–91 600). Interpretation Other musculoskeletal disorders were responsible for a large number of global YLDs in 2020. Until individual conditions and risk factors are more explicitly quantified, policy responses to this burden remain a challenge. Temporal trends and geographical differences in estimates of non-fatal disease burden should not be overinterpreted as they are based on sparse, low-quality data.publishedVersio

Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

Background Rheumatoid arthritis is a chronic autoimmune inflammatory disease associated with disability and premature death. Up-to-date estimates of the burden of rheumatoid arthritis are required for health-care planning, resource allocation, and prevention. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, we provide updated estimates of the prevalence of rheumatoid arthritis and its associated deaths and disability-adjusted life-years (DALYs) by age, sex, year, and location, with forecasted prevalence to 2050. Methods Rheumatoid arthritis prevalence was estimated in 204 countries and territories from 1990 to 2020 using Bayesian meta-regression models and data from population-based studies and medical claims data (98 prevalence and 25 incidence studies). Mortality was estimated from vital registration data with the Cause of Death Ensemble model (CODEm). Years of life lost (YLL) were calculated with use of standard GBD lifetables, and years lived with disability (YLDs) were estimated from prevalence, a meta-analysed distribution of rheumatoid arthritis severity, and disability weights. DALYs were calculated by summing YLLs and YLDs. Smoking was the only risk factor analysed. Rheumatoid arthritis prevalence was forecast to 2050 by logistic regression with Socio-Demographic Index as a predictor, then multiplying by projected population estimates. Findings In 2020, an estimated 17·6 million (95% uncertainty interval 15·8–20·3) people had rheumatoid arthritis worldwide. The age-standardised global prevalence rate was 208·8 cases (186·8–241·1) per 100 000 population, representing a 14·1% (12·7–15·4) increase since 1990. Prevalence was higher in females (age-standardised female-to-male prevalence ratio 2·45 [2·40–2·47]). The age-standardised death rate was 0·47 (0·41–0·54) per 100 000 population (38 300 global deaths [33 500–44 000]), a 23·8% (17·5–29·3) decrease from 1990 to 2020. The 2020 DALY count was 3 060 000 (2 320 000–3 860 000), with an age-standardised DALY rate of 36·4 (27·6–45·9) per 100 000 population. YLDs accounted for 76·4% (68·3–81·0) of DALYs. Smoking risk attribution for rheumatoid arthritis DALYs was 7·1% (3·6–10·3). We forecast that 31·7 million (25·8–39·0) individuals will be living with rheumatoid arthritis worldwide by 2050. Interpretation Rheumatoid arthritis mortality has decreased globally over the past three decades. Global age-standardised prevalence rate and YLDs have increased over the same period, and the number of cases is projected to continue to increase to the year 2050. Improved access to early diagnosis and treatment of rheumatoid arthritis globally is required to reduce the future burden of the disease.publishedVersio

The global burden of cancer attributable to risk factors, 2010-19 : a systematic analysis for the Global Burden of Disease Study 2019

Background Understanding the magnitude of cancer burden attributable to potentially modifiable risk factors is crucial for development of effective prevention and mitigation strategies. We analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 to inform cancer control planning efforts globally. Methods The GBD 2019 comparative risk assessment framework was used to estimate cancer burden attributable to behavioural, environmental and occupational, and metabolic risk factors. A total of 82 risk-outcome pairs were included on the basis of the World Cancer Research Fund criteria. Estimated cancer deaths and disability-adjusted life-years (DALYs) in 2019 and change in these measures between 2010 and 2019 are presented. Findings Globally, in 2019, the risk factors included in this analysis accounted for 4.45 million (95% uncertainty interval 4.01-4.94) deaths and 105 million (95.0-116) DALYs for both sexes combined, representing 44.4% (41.3-48.4) of all cancer deaths and 42.0% (39.1-45.6) of all DALYs. There were 2.88 million (2.60-3.18) risk-attributable cancer deaths in males (50.6% [47.8-54.1] of all male cancer deaths) and 1.58 million (1.36-1.84) risk-attributable cancer deaths in females (36.3% [32.5-41.3] of all female cancer deaths). The leading risk factors at the most detailed level globally for risk-attributable cancer deaths and DALYs in 2019 for both sexes combined were smoking, followed by alcohol use and high BMI. Risk-attributable cancer burden varied by world region and Socio-demographic Index (SDI), with smoking, unsafe sex, and alcohol use being the three leading risk factors for risk-attributable cancer DALYs in low SDI locations in 2019, whereas DALYs in high SDI locations mirrored the top three global risk factor rankings. From 2010 to 2019, global risk-attributable cancer deaths increased by 20.4% (12.6-28.4) and DALYs by 16.8% (8.8-25.0), with the greatest percentage increase in metabolic risks (34.7% [27.9-42.8] and 33.3% [25.8-42.0]). Interpretation The leading risk factors contributing to global cancer burden in 2019 were behavioural, whereas metabolic risk factors saw the largest increases between 2010 and 2019. Reducing exposure to these modifiable risk factors would decrease cancer mortality and DALY rates worldwide, and policies should be tailored appropriately to local cancer risk factor burden. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.Peer reviewe

The built environment and industry/construction 4.0 technologies towards achieving SDGs

Sustainability is not an option; it is a way of living that must rapidly adapt to achieve humanity's sustainability. According to the international energy agency, the construction sector accounts for 36% of energy demand and 40% of energy and process-related emissions. The Fourth Industrial Revolution, also called Industry 4.0, directly impacted how we communicate and interact with others. The transition has faced all industries, including the built environment, by moving to “Construction 4.0” era, accelerating the construction sector’s digitalization and automation, showing the relevance of having trusted real-time information supporting decision-making. This chapter discusses the Construction 4.0 concept and how it disrupts the built environment, leading to how existing professions are growing and emerging new ones. It focuses on the established understanding and expected outcomes of the Construction 4.0 concept and analyzes how they support the SDGs such as SDG 9 (Industry Innovation & Infrastructure) and the digitalization of industrial processes

Survey on Prevalence of Haemoparasites of Trade Camels (Camelus dromedarius) in Maiduguri; Nigeria

Abstract In an attempt to evaluate the prevalence of haemoparasites in trade camels (Camelus dromedarius) slaughtered at the Maiduguri abattoir, whole blood samples were collected and tested. Out of 202 total blood samples collected and examined microscopically for the presence of one or more haemoparasite species an overall prevalence rate of 60.4% was found in Maiduguri. Babesia species 49(24.3%) were found to be more prevalent, followed by Anaplasma species 41(20.3%) and Trypanosoma species 32(15.8%) respectively. Considering the risk factors associated with prevalence of haemoparasites in camels in the study area, higher prevalence was found in female camels 73(36.1%) than the male camels 49(24.3%), although there was no significant statistical difference in prevalence rate amongst the sexes. However, haemoparasitic infection was found to be more frequent in camels during the rainy season 82(40.6%) as compared to dry season 40(19.8%), there was a statistical significant difference (p < 0.0001) between the prevalent rates among the season. It was therefore concluded that there is a high prevalence of haemoparasitic infections in trade camel which may constitute a major health and economic problem in the camel production; therefore there is a need for routine vaccination and periodic medication against haemoparasitic infections of camels in the Arid and Semiarid Northeastern Nigeria